Fin Trust Capital Advisors, LLC United Therapeutics Corp Transaction History
Fin Trust Capital Advisors, LLC
- $577 Million
- Q3 2024
A detailed history of Fin Trust Capital Advisors, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 121 shares of UTHR stock, worth $52,355. This represents 0.01% of its overall portfolio holdings.
Number of Shares
121
Previous 121
-0.0%
Holding current value
$52,355
Previous $38,000
13.16%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding UTHR
# of Institutions
747Shares Held
43.9MCall Options Held
340KPut Options Held
318K-
Black Rock Inc. New York, NY5.47MShares$2.37 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$1.92 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$1.03 Billion12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$938 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$917 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $19.7B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...